Kelly G. Paulson

Kelly G. Paulson

Hematology | Hematology Oncology | Oncology

1221 Madison Street
Seattle, WA 98104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Whole-protein screening and multi-modal profiling of antigen-specific CD4+ T cells at single-cell resolution.

Whole-protein screening and multi-modal profiling of antigen-specific CD4+ T cells at single-cell resolution.

Journal: Nature communications

Published: September 30, 2025

Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study.

Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study.

Journal: The Lancet. Oncology

Published: June 16, 2025

Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.

Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.

Journal: The oncologist

Published: April 22, 2025

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

Journal: Nature communications

Published: March 31, 2025

Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence.

Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence.

Journal: medRxiv : the preprint server for health sciences

Published: January 07, 2025

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy.

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy.

Journal: Journal of the American Academy of Dermatology

Published: December 20, 2024

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.

Journal: Cancer

Published: September 30, 2024

Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma.

Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: July 15, 2024

Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020.

Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020.

Journal: JAMA network open

Published: April 12, 2024

Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.

Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.

Journal: American journal of clinical oncology

Published: September 19, 2023

Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma.

Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma.

Journal: Cell reports. Medicine

Published: July 03, 2023

Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.

Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 29, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026